A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer
Clinical trial NCT06474468 · RECRUITING
Trial details
- NCT number
- NCT06474468
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-20
- Primary completion
- 2026-10-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.